Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS

Clinical trial NCT07322003 · RECRUITING

Trial details

NCT number: NCT07322003
Sponsor: Prilenia
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Amyotrophic Lateral Sclerosis

Start date: 2026-02-01
Primary completion: 2028-03-01
Enrollment: 500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.